Aerovate Therapeutics
AVTE
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)
Categories
Aerovate Therapeutics (AVTE) - Cash on Hand
Cash on Hand as of December 2023 : $0.12 B
According to Aerovate Therapeutics's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aerovate Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -22.8% |
| 2021-12-31 | $0.16 B | 3560.07% |
| 2020-12-31 | $4.57 M | 30.14% |
| 2019-12-31 | $3.51 M |